Goldman Sachs reiterated its Buy rating on Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) shares with a steady price target of $78.00. The firm's analyst highlighted Ultragenyx's fourth-quarter total ...

Barclays has entered the crypto market with a $131 million investment in the iShares Bitcoin Trust (IBIT), a Bitcoin ETF ...

CNBC projected that the emergence of cheaper AI models from China could increase the demand for data centers. Analysts ...

The rise of China's DeepSeek AI model is boosting Chinese tech firms including Alibaba, Baidu, and Xiaomi.

Hong Kong-listed Chinese stocks extended their recent rally on Friday, fueled by growing optimism surrounding the nation's ...

An industry-leading position and strong secular tailwinds should help drive this artificial intelligence (AI) pioneer higher.

Despite an initial knee-jerk reaction from markets, experts told CNBC that cheaper and more efficient AI models could ...

We recently compiled a list of the 10 Best Bank Dividend Stocks To Buy Right Now. In this article, we are going to take a ...

Austin-based identity security company SailPoint Inc. went public Feb. 13 and raised about $1.38 billion in an initial public ...

A new study argues that data centers could be ideal demand-response participants because they have the potential to be ...

We recently compiled a list of the Top 10 Stocks to Buy According to Lee Munder Capital Group. In this article, we are going to take a look at where The Goldman Sachs Group, Inc.

The good news is that this move has been positively impacting the company's growth. The impact of AI on Cloudflare's growth ...